Paolo Durigutto

2.2k total citations
31 papers, 1.6k citations indexed

About

Paolo Durigutto is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Paolo Durigutto has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Rheumatology and 11 papers in Hematology. Recurrent topics in Paolo Durigutto's work include Complement system in diseases (11 papers), Systemic Lupus Erythematosus Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Paolo Durigutto is often cited by papers focused on Complement system in diseases (11 papers), Systemic Lupus Erythematosus Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Paolo Durigutto collaborates with scholars based in Italy, United Kingdom and United States. Paolo Durigutto's co-authors include Francesco Tedesco, Pier Luigi Meroni, Roberta Bulla, Fabio Fischetti, Paolo Macor, Fleur Bossi, Chiara Agostinis, Daniele Sblattero, María Orietta Borghi and C. Grossi and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Paolo Durigutto

28 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Durigutto Italy	21	715	658	421	248	185	31	1.6k
Liliane Fossati‐Jimack United Kingdom	27	1.6k 2.2×	444 0.7×	260 0.6×	448 1.8×	138 0.7×	65	2.1k
Maryvonne Dueymes France	21	592 0.8×	539 0.8×	143 0.3×	288 1.2×	206 1.1×	60	1.5k
Josep Ordi‐Ros Spain	30	940 1.3×	1.4k 2.1×	372 0.9×	738 3.0×	144 0.8×	69	2.6k
Birgitta Gullstrand Sweden	27	1.7k 2.3×	954 1.4×	351 0.8×	706 2.8×	69 0.4×	57	2.4k
Bernd M. Spriewald Germany	26	790 1.1×	199 0.3×	176 0.4×	228 0.9×	443 2.4×	74	1.7k
Salima Sadallah Switzerland	22	921 1.3×	251 0.4×	308 0.7×	643 2.6×	57 0.3×	46	1.7k
Pojen Chen United States	12	978 1.4×	651 1.0×	287 0.7×	462 1.9×	51 0.3×	14	1.7k
Yuko Shirota Japan	17	1.1k 1.5×	641 1.0×	142 0.3×	184 0.7×	73 0.4×	47	1.7k
Hideki Amuro Japan	16	1.1k 1.6×	639 1.0×	181 0.4×	326 1.3×	60 0.3×	41	1.7k
James Chung United States	21	966 1.4×	559 0.8×	225 0.5×	135 0.5×	120 0.6×	45	1.5k

Countries citing papers authored by Paolo Durigutto

Since Specialization

Citations

This map shows the geographic impact of Paolo Durigutto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Durigutto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Durigutto more than expected).

Fields of papers citing papers by Paolo Durigutto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Durigutto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Durigutto. The network helps show where Paolo Durigutto may publish in the future.

Co-authorship network of co-authors of Paolo Durigutto

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Durigutto. A scholar is included among the top collaborators of Paolo Durigutto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Durigutto. Paolo Durigutto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Durigutto, Paolo, et al.. (2025). β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model. Frontiers in Immunology. 16. 1520619–1520619.

Argenziano, Monica, Paolo Durigutto, Alessandro Mangogna, et al.. (2025). Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma. Nanomedicine. 20(3). 255–270.

Durigutto, Paolo, et al.. (2023). A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma. Journal of Translational Medicine. 21(1). 864–864. 1 indexed citations

Macor, Paolo, Paolo Durigutto, Monica Argenziano, et al.. (2022). Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy. Haematologica. 108(7). 1861–1872. 10 indexed citations

Meroni, Pier Luigi, María Orietta Borghi, C. Grossi, et al.. (2018). Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?. Nature Reviews Rheumatology. 14(7). 433–440. 110 indexed citations

Durigutto, Paolo, C. Grossi, María Orietta Borghi, et al.. (2018). New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats. Haematologica. 104(4). 819–826. 42 indexed citations

Bulla, Roberta, Claudio Tripodo, Damiano Rami, et al.. (2016). C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nature Communications. 7(1). 10346–10346. 223 indexed citations

Petitbarat, Marie, Paolo Durigutto, Paolo Macor, et al.. (2015). Critical Role and Therapeutic Control of the Lectin Pathway of Complement Activation in an Abortion-Prone Mouse Mating. The Journal of Immunology. 195(12). 5602–5607. 30 indexed citations

Agostinis, Chiara, Paolo Durigutto, Daniele Sblattero, et al.. (2014). A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. Blood. 123(22). 3478–3487. 106 indexed citations

10.

Macor, Paolo, Sonia Zorzet, Paolo Durigutto, et al.. (2014). Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. Leukemia. 29(2). 406–414. 70 indexed citations

11.

Agostinis, Chiara, Paolo Durigutto, Daniele Sblattero, et al.. (2013). A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models.. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 65. 245–245. 3 indexed citations

12.

Codolo, Gaia, Fleur Bossi, Paolo Durigutto, et al.. (2013). Orchestration of Inflammation and Adaptive Immunity in Borrelia burgdorferi–Induced Arthritis by Neutrophil‐Activating Protein A. Arthritis & Rheumatism. 65(5). 1232–1242. 32 indexed citations

13.

Durigutto, Paolo, Paolo Macor, Luca De Maso, et al.. (2013). Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5. PLoS ONE. 8(3). e58696–e58696. 20 indexed citations

14.

Fischetti, Fabio, Riccardo Candido, Barbara Toffoli, et al.. (2011). Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. Atherosclerosis. 216(1). 83–89. 10 indexed citations

15.

Bulla, Roberta, Francesco De Seta, Oriano Radillo, et al.. (2010). Mannose-binding lectin is produced by vaginal epithelial cells and its level in the vaginal fluid is influenced by progesterone. Molecular Immunology. 48(1-3). 281–286. 31 indexed citations

16.

Bossi, Fleur, Fabio Fischetti, D. Regoli, et al.. (2009). Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. Journal of Allergy and Clinical Immunology. 124(6). 1303–1310.e4. 78 indexed citations

17.

Ferraresso, Mariano, Paolo Macor, Marialuisa Valente, et al.. (2008). Posttransplant Ischemia-Reperfusion Injury In Transplanted Heart Is Prevented By A Minibody to the Fifth Component of Complement. Transplantation. 86(10). 1445–1451. 23 indexed citations

18.

Bossi, Fleur, Fabio Fischetti, Paolo Durigutto, et al.. (2007). The Neutrophil-Activating Protein of Helicobacter pylori Crosses Endothelia to Promote Neutrophil Adhesion In Vivo. The Journal of Immunology. 178(3). 1312–1320. 77 indexed citations

19.

Fischetti, Fabio, Paolo Durigutto, Paolo Macor, et al.. (2007). Selective therapeutic control of C5a and the terminal complement complex by anti‐C5 single‐chain Fv in an experimental model of antigen‐induced arthritis in rats. Arthritis & Rheumatism. 56(4). 1187–1197. 31 indexed citations

20.

Fischetti, Fabio, Renzo Carretta, Paolo Durigutto, et al.. (2004). ”Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflamation”F.Fischetti, R. Carretta, G. Borotto, P. Durigutto, R. Bulla, P.L. Meroni, F. Tedesco.. Clinical & Experimental Immunology. 186–193.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact